Company · CIK 0001426332
NGM BIOPHARMACEUTICALS INC
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13D/ANGM BIOPHARMACEUTICALS INC0000950142-24-000985 · 343.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-24-088076 · 272.5 KBSEC(opens sec.gov)
- 10-K/ANGM BIOPHARMACEUTICALS INC0001628280-24-014888 · 760.3 KBSEC(opens sec.gov)
- 10-KAnnual report0001628280-24-010232 · 9.6 MBSEC(opens sec.gov)
- 8-KCurrent report0001628280-24-010229 · 298.0 KBSEC(opens sec.gov)
- SC 13D/ANGM BIOPHARMACEUTICALS INC0000950142-24-000549 · 1.0 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-24-046296 · 882.0 KBSEC(opens sec.gov)
- SC 13G/ANGM BIOPHARMACEUTICALS INC0000935836-24-000216 · 47.2 KBSEC(opens sec.gov)
- SC 13G/ANGM BIOPHARMACEUTICALS INC0001104659-24-021563 · 13.1 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-24-011619 · 140.0 KBSEC(opens sec.gov)
Insiders
- CHEN JIN-LONGDirector, Chief Scientific Officer
- COLUMN GROUP GP, LP10% Owner
- Column Group II GP, LP10% Owner
- COLUMN GROUP III-A, LP10% Owner
- COLUMN GROUP III GP, LP10% Owner
- COLUMN GROUP III, LP10% Owner
- COLUMN GROUP II, LP10% Owner
- Column Group IV-A, LP10% Owner
- Column Group IV GP, LP10% Owner
- COLUMN GROUP L PDirector, 10% Owner
Tickers
No tickers on record.
Addresses
business
333 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA, 94080
mailing
333 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA, 94080
Same industry